|
1
|
Kingman S: Glaucoma is second leading
cause of blindness globally. Bull World Health Organ. 82:887–888.
2004.PubMed/NCBI
|
|
2
|
Quigley HA: Glaucoma. Lancet.
377:1367–1377. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gasiorowski JZ and Russell P: Biological
properties of trabecular meshwork cells. Exp Eye Res. 88:671–675.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mozaffarieh M, Grieshaber MC and Flammer
J: Oxygen and blood flow: Players in the pathogenesis of glaucoma.
Mol Vis. 14:224–233. 2008.PubMed/NCBI
|
|
5
|
Tektas OY and Lütjen-Drecoll E: Structural
changes of the trabecular meshwork in different kinds of glaucoma.
Exp Eye Res. 88:769–775. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hausser J and Zavolan M: Identification
and consequences of miRNA-target interactions-beyond repression of
gene expression. Nat Rev Genet. 15:599–612. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Asirvatham AJ, Magner WJ and Tomasi TB:
miRNA regulation of cytokine genes. Cytokine. 45:58–69. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu L and Belasco JG: Let me count the
ways: Mechanisms of gene regulation by miRNAs and siRNAs. Mol Cell.
29:1–7. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Georges M, Coppieters W and Charlier C:
Polymorphic miRNA-mediated gene regulation: Contribution to
phenotypic variation and disease. Curr Opin Genet Dev. 17:166–176.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Das J, Podder S and Ghosh TC: Insights
into the miRNA regulations in human disease genes. BMC Genomics.
15:10102014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Luna C, Li G, Huang J, Qiu J, Wu J, Yuan
F, Epstein DL and Gonzalez P: Regulation of trabecular meshwork
cell contraction and intraocular pressure by miR-200c. PLoS One.
7:e516882012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li G, Luna C, Qiu J, Epstein DL and
Gonzalez P: Alterations in microRNA expression in stress-induced
cellular senescence. Mech Ageing Dev. 130:731–741. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li G, Luna C, Qiu J, Epstein DL and
Gonzalez P: Targeting of integrin beta1 and kinesin 2alpha by
microRNA 183. J Biol Chem. 285:5461–5471. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu XF, Zou J, Bao ZJ and Dong J: miR-93
suppresses proliferation and colony formation of human colon cancer
stem cells. World J Gastroenterol. 17:4711–4717. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Du L, Schageman JJ, Subauste MC, Saber B,
Hammond SM, Prudkin L, Wistuba II, Ji L, Roth JA, Minna JD and
Pertsemlidis A: miR-93, miR-98, and miR-197 regulate expression of
tumor suppressor gene FUS1. Mol Cancer Res. 7:1234–1243. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Singh B, Ronghe AM, Chatterjee A, Bhat NK
and Bhat HK: MicroRNA-93 regulates NRF2 expression and is
associated with breast carcinogenesis. Carcinogenesis.
34:1165–1172. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Izzotti A, Saccà SC, Longobardi M and
Cartiglia C: Mitochondrial damage in the trabecular meshwork of
patients with glaucoma. Arch Ophthalmol. 128:724–730. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Saccà SC and Izzotti A: Focus on molecular
events in the anterior chamber leading to glaucoma. Cell Mol Life
Sci. 71:2197–2218. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kensler TW, Wakabayashi N and Biswal S:
Cell survival responses to environmental stresses via the
Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol. 47:89–116.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
He X, Lin GX, Chen MG, Zhang JX and Ma Q:
Protection against chromium (VI)-induced oxidative stress and
apoptosis by Nrf2. Recruiting Nrf2 into the nucleus and disrupting
the nuclear Nrf2/Keap1 association. Toxicol Sci. 98:298–309. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vargas MR, Pehar M, Cassina P, Beckman JS
and Barbeito L: Increased glutathione biosynthesis by Nrf2
activation in astrocytes prevents p75NTR-dependent motor neuron
apoptosis. J Neurochem. 97:687–696. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Singh A, Boldin-Adamsky S, Thimmulappa RK,
Rath SK, Ashush H, Coulter J, Blackford A, Goodman SN, Bunz F,
Watson WH, et al: RNAi-mediated silencing of nuclear factor
erythroid-2-related factor 2 gene expression in non-small cell lung
cancer inhibits tumor growth and increases efficacy of
chemotherapy. Cancer Res. 68:7975–7984. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Narasimhan M, Mahimainathan L, Rathinam
ML, Riar AK and Henderson GI: Overexpression of Nrf2 protects
cerebral cortical neurons from ethanol-induced apoptotic death. Mol
Pharmacol. 80:988–999. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Son YO, Pratheeshkumar P, Roy RV, Hitron
JA, Wang L, Zhang Z and Shi X: Nrf2/p62 signaling in apoptosis
resistance and its role in cadmium-induced carcinogenesis. J Biol
Chem. 289:28660–28675. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bhakkiyalakshmi E, Shalini D, Sekar TV,
Rajaguru P, Paulmurugan R and Ramkumar KM: Therapeutic potential of
pterostilbene against pancreatic beta-cell apoptosis mediated
through Nrf2. Br JPharmacol. 171:1747–1757. 2014. View Article : Google Scholar
|
|
27
|
Long J, Wang Y, Wang W, Chang BH and
Danesh FR: Identification of microRNA-93 as a novel regulator of
vascular endothelial growth factor in hyperglycemic conditions. J
Biol Chem. 285:23457–23465. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fu X, Tian J, Zhang L, Chen Y and Hao Q:
Involvement of microRNA-93, a new regulator of PTEN/Akt signaling
pathway, in regulation of chemotherapeutic drug cisplatin
chemosensitivity in ovarian cancer cells. FEBS Lett. 586:1279–1286.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang IP, Tsai HL, Hou MF, Chen KC, Tsai
PC, Huang SW, Chou WW, Wang JY and Juo SH: MicroRNA-93 inhibits
tumor growth and early relapse of human colorectal cancer by
affecting genes involved in the cell cycle. Carcinogenesis.
33:1522–1530. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Goto Y, Kojima S, Nishikawa R, Enokida H,
Chiyomaru T, Kinoshita T, Nakagawa M, Naya Y, Ichikawa T and Seki
N: The microRNA-23b/27b/24-1 cluster is a disease progression
marker and tumor suppressor in prostate cancer. Oncotarget.
5:7748–7759. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lattanzi A, Gentner B, Corno D, Di Tomaso
T, Mestdagh P, Speleman F, Naldini L and Gritti A: Dynamic activity
of miR-125b and miR-93 during murine neural stem cell
differentiation in vitro and in the Subventricular Zone Neurogenic
Niche. PLoS One. 8:e674112013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gentner B, Visigalli I, Hiramatsu H,
Lechman E, Ungari S, Giustacchini A, Schira G, Amendola M,
Quattrini A, Martino S, et al: Identification of hematopoietic stem
cell-specific miRNAs enables gene therapy of globoid cell
leukodystrophy. Sci Transl Med. 2:58ra842010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tian B and Kaufman PL: A potential
application of canaloplasty in glaucoma gene therapy. Transl Vis
Sci Technol. 2pii(2)2013.
|
|
34
|
Aktas Z, Tian B, McDonald J, Yamamato R,
Larsen C, Kiland J, Kaufman PL and Rasmussen CA: Application of
canaloplasty in glaucoma gene therapy: Where are we? J Ocul
Pharmacol Ther. 30:277–282. 2014. View Article : Google Scholar : PubMed/NCBI
|
